Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity

Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial

(2012) Khatereh Sepanjnia et al.   NEUROPSYCHOPHARMACOLOGY

Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression

(2012) M Guo et al.   Translational Psychiatry

Adiponectin Stimulates Proliferation of Adult Hippocampal Neural Stem/Progenitor Cells through Activation of p38 Mitogen-activated Protein Kinase (p38MAPK)/Glycogen Synthase Kinase 3β (GSK-3β)/β-Catenin Signaling Cascade

(2011) Di Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala

(2011) J Liu et al.   MOLECULAR PSYCHIATRY

Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

(2011) E Beurel et al.   MOLECULAR PSYCHIATRY

Antiobesity activities of indole-3-carbinol in high-fat-diet–induced obese mice

(2011) Hsiao-Pei Chang et al.   NUTRITION

Cognitive and neural correlates of depression-like behaviour in socially defeated mice: an animal model of depression with cognitive dysfunction

(2010) Tao Yu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Inflammatory Biomarkers in 70 Depressed Inpatients With and Without the Metabolic Syndrome

(2010) Sara Zeugmann et al.   JOURNAL OF CLINICAL PSYCHIATRY

Low 24-Hour Adiponectin and High Nocturnal Leptin Concentrations in a Case-Control Study of Community-Dwelling Premenopausal Women With Major Depressive Disorder

(2010) Giovanni Cizza et al.   JOURNAL OF CLINICAL PSYCHIATRY

Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?

(2010) Xiaohua Li et al.   NEUROPSYCHOPHARMACOLOGY

Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice

(2010) Min He et al.   PLoS One

Serum adiponectin and resistin levels in major depressive disorder

(2009) S. M. Lehto et al.   ACTA PSYCHIATRICA SCANDINAVICA

Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus

(2009) Frank Andersohn et al.   AMERICAN JOURNAL OF PSYCHIATRY

Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests

(2009) Amany Ali Eissa Ahmed et al.   BEHAVIOURAL PHARMACOLOGY

Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine

(2009) Jing Liu et al.   PSYCHOPHARMACOLOGY

Impact of Increased PPARγ Activity in Adipocytes in vivo on Adiposity, Insulin Sensitivity and the Effects of Rosiglitazone Treatment

(2008) Katsuko TAKASAWA et al.   ENDOCRINE JOURNAL

The HPA axis in major depression: classical theories and new developments

(2008) Carmine M. Pariante et al.   TRENDS IN NEUROSCIENCES

Type of antidepressant therapy and risk of type 2 diabetes in people with depression

(2007) Lauren C. Brown et al.   DIABETES RESEARCH AND CLINICAL PRACTICE